Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more
Renhe Pharmacy Co Ltd - Asset Resilience Ratio
Renhe Pharmacy Co Ltd (000650) has an Asset Resilience Ratio of 35.97% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how Renhe Pharmacy Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Renhe Pharmacy Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥2.91 Billion | 35.97% |
| Total Liquid Assets | CN¥2.91 Billion | 35.97% |
Asset Resilience Insights
- Very High Liquidity: Renhe Pharmacy Co Ltd maintains exceptional liquid asset reserves at 35.97% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Renhe Pharmacy Co Ltd Industry Peers by Asset Resilience Ratio
Compare Renhe Pharmacy Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Renhe Pharmacy Co Ltd (2009–2024)
The table below shows the annual Asset Resilience Ratio data for Renhe Pharmacy Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 13.59% | CN¥1.02 Billion | CN¥7.48 Billion | +1.24pp |
| 2023-12-31 | 12.36% | CN¥919.96 Million | CN¥7.44 Billion | +6.89pp |
| 2022-12-31 | 5.46% | CN¥416.87 Million | CN¥7.63 Billion | +0.89pp |
| 2021-12-31 | 4.57% | CN¥315.60 Million | CN¥6.91 Billion | -2.74pp |
| 2020-12-31 | 7.31% | CN¥460.89 Million | CN¥6.31 Billion | -8.84pp |
| 2019-12-31 | 16.15% | CN¥805.14 Million | CN¥4.98 Billion | +15.98pp |
| 2018-12-31 | 0.17% | CN¥7.86 Million | CN¥4.62 Billion | -0.07pp |
| 2017-12-31 | 0.24% | CN¥9.99 Million | CN¥4.17 Billion | +0.01pp |
| 2016-12-31 | 0.23% | CN¥8.81 Million | CN¥3.86 Billion | -0.03pp |
| 2015-12-31 | 0.26% | CN¥8.21 Million | CN¥3.16 Billion | +0.00pp |
| 2014-12-31 | 0.26% | CN¥6.73 Million | CN¥2.60 Billion | +0.04pp |
| 2013-12-31 | 0.22% | CN¥5.22 Million | CN¥2.33 Billion | -0.04pp |
| 2012-12-31 | 0.26% | CN¥5.54 Million | CN¥2.09 Billion | -0.25pp |
| 2011-12-31 | 0.52% | CN¥8.29 Million | CN¥1.60 Billion | -0.11pp |
| 2010-12-31 | 0.63% | CN¥9.25 Million | CN¥1.48 Billion | -0.12pp |
| 2009-12-31 | 0.74% | CN¥7.88 Million | CN¥1.06 Billion | -- |